Erwan Pencreach
Institut National de la Santé et de la Recherche Médicale U682
Service de Biochimie et Biologie Moléculaire
Hôpital de Hautepierre Hôpitaux Universitaires de Strasbourg
Strasbourg
France
Name/email consistency: high
- Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis. Pencreach, E., Guérin, E., Nicolet, C., Lelong-Rebel, I., Voegeli, A.C., Oudet, P., Larsen, A.K., Gaub, M.P., Guenot, D. Clin. Cancer Res. (2009)









